A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Cure Vac N.V. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 8,113 shares of CVAC stock, worth $21,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,113
Previous 6,697 21.14%
Holding current value
$21,580
Previous $22,000 4.55%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$2.74 - $3.79 $3,879 - $5,366
1,416 Added 21.14%
8,113 $23,000
Q2 2024

Jul 30, 2024

BUY
$2.31 - $4.99 $15,470 - $33,418
6,697 New
6,697 $22,000
Q2 2023

Aug 10, 2023

BUY
$6.69 - $12.25 $25,462 - $46,623
3,806 Added 32.99%
15,342 $159,000
Q1 2023

May 04, 2023

SELL
$6.38 - $12.5 $7,081 - $13,875
-1,110 Reduced 8.78%
11,536 $80,000
Q4 2022

Feb 09, 2023

BUY
$5.75 - $8.5 $72,714 - $107,491
12,646 New
12,646 $76,000

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $499M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.